 | Esperion Therapeutics, Inc. | |||
| NGM : ESPR || Location: United States | ||||
$1.91-0.04 (-2.05%) |
4.79 M | 1.84 - 1.97 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 19.922 M |
| March 15, 2024 | 17.666 M |
| Feb. 29, 2024 | 16.951 M |
| Feb. 15, 2024 | 18.569 M |
| Jan. 31, 2024 | 20.068 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.49 | -0.50 | -1.58% |
| 09/30/2023 | -0.44 | -0.37 | 16.08% |
| 06/30/2023 | -0.62 | -0.46 | 26.23% |
| 03/31/2023 | -0.67 | -0.79 | -18.73% |
| 12/31/2022 | -0.86 | -0.76 | 11.37% |
ESPR Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 189.401M | Shares Float | 184.028M |
| Short Float | 19.922M | Market Cap | 361.76M |
| Institution ownership | 39.19% | Insider ownership | 0.450% |
| Earnings Date | 05/08/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.03 | Forward EPS | 0.05 |